nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0246	0.0406	CbGbCtD
Mirtazapine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0246	0.0406	CbGbCtD
Mirtazapine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0224	0.0369	CbGbCtD
Mirtazapine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.021	0.0347	CbGbCtD
Mirtazapine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.021	0.0347	CbGbCtD
Mirtazapine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0201	0.0333	CbGbCtD
Mirtazapine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.019	0.0314	CbGbCtD
Mirtazapine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0189	0.0313	CbGbCtD
Mirtazapine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0189	0.0313	CbGbCtD
Mirtazapine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0186	0.0307	CbGbCtD
Mirtazapine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0186	0.0307	CbGbCtD
Mirtazapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0184	0.0304	CbGbCtD
Mirtazapine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0178	0.0295	CbGbCtD
Mirtazapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0173	0.0286	CbGbCtD
Mirtazapine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0173	0.0286	CbGbCtD
Mirtazapine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0171	0.0283	CbGbCtD
Mirtazapine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0171	0.0283	CbGbCtD
Mirtazapine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0159	0.0263	CbGbCtD
Mirtazapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0259	CbGbCtD
Mirtazapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0259	CbGbCtD
Mirtazapine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0148	0.0244	CbGbCtD
Mirtazapine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0144	0.0238	CbGbCtD
Mirtazapine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0237	CbGbCtD
Mirtazapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0135	0.0223	CbGbCtD
Mirtazapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0131	0.0217	CbGbCtD
Mirtazapine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.013	0.0214	CbGbCtD
Mirtazapine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.013	0.0214	CbGbCtD
Mirtazapine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0124	0.0206	CbGbCtD
Mirtazapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0196	CbGbCtD
Mirtazapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0196	CbGbCtD
Mirtazapine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0117	0.0193	CbGbCtD
Mirtazapine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.011	0.0182	CbGbCtD
Mirtazapine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.011	0.0182	CbGbCtD
Mirtazapine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00996	0.0165	CbGbCtD
Mirtazapine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00996	0.0165	CbGbCtD
Mirtazapine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0086	0.0142	CbGbCtD
Mirtazapine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00834	0.0138	CbGbCtD
Mirtazapine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00755	0.0125	CbGbCtD
Mirtazapine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00755	0.0125	CbGbCtD
Mirtazapine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00723	0.012	CbGbCtD
Mirtazapine—HTR3A—nerve—acquired immunodeficiency syndrome	0.00223	0.0337	CbGeAlD
Mirtazapine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00186	0.028	CbGeAlD
Mirtazapine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.0015	0.0226	CbGeAlD
Mirtazapine—HTR7—nerve—acquired immunodeficiency syndrome	0.00145	0.0218	CbGeAlD
Mirtazapine—DRD2—nerve—acquired immunodeficiency syndrome	0.00137	0.0206	CbGeAlD
Mirtazapine—HRH3—digestive system—acquired immunodeficiency syndrome	0.00136	0.0204	CbGeAlD
Mirtazapine—HRH3—blood—acquired immunodeficiency syndrome	0.00129	0.0195	CbGeAlD
Mirtazapine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00129	0.0194	CbGeAlD
Mirtazapine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00123	0.0186	CbGeAlD
Mirtazapine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00114	0.0172	CbGeAlD
Mirtazapine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00109	0.0165	CbGeAlD
Mirtazapine—HRH3—nervous system—acquired immunodeficiency syndrome	0.00105	0.0158	CbGeAlD
Mirtazapine—HRH3—central nervous system—acquired immunodeficiency syndrome	0.00101	0.0152	CbGeAlD
Mirtazapine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000932	0.014	CbGeAlD
Mirtazapine—HTR2A—nerve—acquired immunodeficiency syndrome	0.000902	0.0136	CbGeAlD
Mirtazapine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000872	0.0131	CbGeAlD
Mirtazapine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000828	0.0125	CbGeAlD
Mirtazapine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000802	0.0121	CbGeAlD
Mirtazapine—HRH3—brain—acquired immunodeficiency syndrome	0.000801	0.0121	CbGeAlD
Mirtazapine—DRD4—brain—acquired immunodeficiency syndrome	0.00079	0.0119	CbGeAlD
Mirtazapine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000768	0.0116	CbGeAlD
Mirtazapine—DRD3—nervous system—acquired immunodeficiency syndrome	0.000727	0.011	CbGeAlD
Mirtazapine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.0007	0.0105	CbGeAlD
Mirtazapine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000682	0.0103	CbGeAlD
Mirtazapine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.00065	0.0098	CbGeAlD
Mirtazapine—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000648	0.00976	CbGeAlD
Mirtazapine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000631	0.00952	CbGeAlD
Mirtazapine—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000624	0.0094	CbGeAlD
Mirtazapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000621	0.00936	CbGeAlD
Mirtazapine—HTR3A—blood—acquired immunodeficiency syndrome	0.000619	0.00933	CbGeAlD
Mirtazapine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000614	0.00925	CbGeAlD
Mirtazapine—DRD2—retina—acquired immunodeficiency syndrome	0.000566	0.00853	CbGeAlD
Mirtazapine—DRD3—brain—acquired immunodeficiency syndrome	0.000555	0.00837	CbGeAlD
Mirtazapine—HTR3A—lung—acquired immunodeficiency syndrome	0.000543	0.00818	CbGeAlD
Mirtazapine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000503	0.00758	CbGeAlD
Mirtazapine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000496	0.00748	CbGeAlD
Mirtazapine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000496	0.00747	CbGeAlD
Mirtazapine—OPRK1—brain—acquired immunodeficiency syndrome	0.000495	0.00746	CbGeAlD
Mirtazapine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000491	0.0074	CbGeAlD
Mirtazapine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000484	0.00729	CbGeAlD
Mirtazapine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00048	0.00723	CbGeAlD
Mirtazapine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000472	0.00712	CbGeAlD
Mirtazapine—HTR2B—blood—acquired immunodeficiency syndrome	0.000468	0.00705	CbGeAlD
Mirtazapine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000455	0.00686	CbGeAlD
Mirtazapine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000452	0.00681	CbGeAlD
Mirtazapine—HTR2B—vagina—acquired immunodeficiency syndrome	0.000434	0.00654	CbGeAlD
Mirtazapine—ADRB1—lung—acquired immunodeficiency syndrome	0.000428	0.00646	CbGeAlD
Mirtazapine—HTR7—digestive system—acquired immunodeficiency syndrome	0.00042	0.00634	CbGeAlD
Mirtazapine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000418	0.0063	CbGeAlD
Mirtazapine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000414	0.00624	CbGeAlD
Mirtazapine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000411	0.00619	CbGeAlD
Mirtazapine—HTR2B—lung—acquired immunodeficiency syndrome	0.00041	0.00618	CbGeAlD
Mirtazapine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000404	0.00609	CbGeAlD
Mirtazapine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000404	0.00609	CbGeAlD
Mirtazapine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000403	0.00607	CbGeAlD
Mirtazapine—HTR7—blood—acquired immunodeficiency syndrome	0.000401	0.00604	CbGeAlD
Mirtazapine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000397	0.00598	CbGeAlD
Mirtazapine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000389	0.00587	CbGeAlD
Mirtazapine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000386	0.00582	CbGeAlD
Mirtazapine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000386	0.00582	CbGeAlD
Mirtazapine—HTR3A—brain—acquired immunodeficiency syndrome	0.000384	0.00579	CbGeAlD
Mirtazapine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000383	0.00578	CbGeAlD
Mirtazapine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000382	0.00576	CbGeAlD
Mirtazapine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00038	0.00572	CbGeAlD
Mirtazapine—HTR2A—retina—acquired immunodeficiency syndrome	0.000373	0.00563	CbGeAlD
Mirtazapine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000369	0.00556	CbGeAlD
Mirtazapine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000368	0.00555	CbGeAlD
Mirtazapine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00551	CbGeAlD
Mirtazapine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000364	0.00549	CbGeAlD
Mirtazapine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000355	0.00535	CbGeAlD
Mirtazapine—HTR7—lung—acquired immunodeficiency syndrome	0.000351	0.00529	CbGeAlD
Mirtazapine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000341	0.00515	CbGeAlD
Mirtazapine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000341	0.00514	CbGeAlD
Mirtazapine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00034	0.00513	CbGeAlD
Mirtazapine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000337	0.00509	CbGeAlD
Mirtazapine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000335	0.00506	CbGeAlD
Mirtazapine—DRD2—lung—acquired immunodeficiency syndrome	0.000332	0.005	CbGeAlD
Mirtazapine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000328	0.00494	CbGeAlD
Mirtazapine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000325	0.0049	CbGeAlD
Mirtazapine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000325	0.0049	CbGeAlD
Mirtazapine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000323	0.00487	CbGeAlD
Mirtazapine—SLC6A3—brain—acquired immunodeficiency syndrome	0.00032	0.00482	CbGeAlD
Mirtazapine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000319	0.00482	CbGeAlD
Mirtazapine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000318	0.0048	CbGeAlD
Mirtazapine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000316	0.00477	CbGeAlD
Mirtazapine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000314	0.00473	CbGeAlD
Mirtazapine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000314	0.00473	CbGeAlD
Mirtazapine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000313	0.00472	CbGeAlD
Mirtazapine—HTR2C—brain—acquired immunodeficiency syndrome	0.000309	0.00466	CbGeAlD
Mirtazapine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000307	0.00463	CbGeAlD
Mirtazapine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000303	0.00457	CbGeAlD
Mirtazapine—ADRB1—brain—acquired immunodeficiency syndrome	0.000303	0.00457	CbGeAlD
Mirtazapine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000302	0.00455	CbGeAlD
Mirtazapine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000299	0.00451	CbGeAlD
Mirtazapine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000296	0.00446	CbGeAlD
Mirtazapine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000294	0.00443	CbGeAlD
Mirtazapine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000293	0.00442	CbGeAlD
Mirtazapine—HTR2B—brain—acquired immunodeficiency syndrome	0.00029	0.00438	CbGeAlD
Mirtazapine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000288	0.00434	CbGeAlD
Mirtazapine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000283	0.00427	CbGeAlD
Mirtazapine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00028	0.00423	CbGeAlD
Mirtazapine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00028	0.00422	CbGeAlD
Mirtazapine—HRH1—vagina—acquired immunodeficiency syndrome	0.000277	0.00418	CbGeAlD
Mirtazapine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000272	0.0041	CbGeAlD
Mirtazapine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000262	0.00395	CbGeAlD
Mirtazapine—HRH1—lung—acquired immunodeficiency syndrome	0.000262	0.00395	CbGeAlD
Mirtazapine—HTR1A—brain—acquired immunodeficiency syndrome	0.00026	0.00392	CbGeAlD
Mirtazapine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000258	0.00389	CbGeAlD
Mirtazapine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000258	0.00388	CbGeAlD
Mirtazapine—HTR2A—blood—acquired immunodeficiency syndrome	0.00025	0.00377	CbGeAlD
Mirtazapine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000249	0.00376	CbGeAlD
Mirtazapine—HTR7—brain—acquired immunodeficiency syndrome	0.000249	0.00375	CbGeAlD
Mirtazapine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000243	0.00366	CbGeAlD
Mirtazapine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000243	0.00366	CbGeAlD
Mirtazapine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000241	0.00363	CbGeAlD
Mirtazapine—ADRA1A—brain—acquired immunodeficiency syndrome	0.00024	0.00361	CbGeAlD
Mirtazapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000239	0.0036	CbGeAlD
Mirtazapine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000238	0.00359	CbGeAlD
Mirtazapine—DRD2—brain—acquired immunodeficiency syndrome	0.000235	0.00354	CbGeAlD
Mirtazapine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000234	0.00352	CbGeAlD
Mirtazapine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000232	0.00349	CbGeAlD
Mirtazapine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000231	0.00349	CbGeAlD
Mirtazapine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00023	0.00346	CbGeAlD
Mirtazapine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000228	0.00344	CbGeAlD
Mirtazapine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000228	0.00343	CbGeAlD
Mirtazapine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000221	0.00333	CbGeAlD
Mirtazapine—HTR2A—lung—acquired immunodeficiency syndrome	0.000219	0.0033	CbGeAlD
Mirtazapine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000212	0.00319	CbGeAlD
Mirtazapine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000203	0.00306	CbGeAlD
Mirtazapine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000195	0.00294	CbGeAlD
Mirtazapine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000188	0.00283	CbGeAlD
Mirtazapine—HRH1—brain—acquired immunodeficiency syndrome	0.000186	0.0028	CbGeAlD
Mirtazapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000185	0.00278	CbGeAlD
Mirtazapine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000182	0.00275	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000181	0.00272	CbGeAlD
Mirtazapine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000179	0.0027	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000178	0.00268	CbGeAlD
Mirtazapine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000176	0.00266	CbGeAlD
Mirtazapine—HTR2A—brain—acquired immunodeficiency syndrome	0.000155	0.00234	CbGeAlD
Mirtazapine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000141	0.00213	CbGeAlD
Mirtazapine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	9.36e-05	0.000347	CcSEcCtD
Mirtazapine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	9.33e-05	0.000346	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000346	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.3e-05	0.000344	CcSEcCtD
Mirtazapine—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.29e-05	0.000344	CcSEcCtD
Mirtazapine—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.29e-05	0.000344	CcSEcCtD
Mirtazapine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.28e-05	0.000344	CcSEcCtD
Mirtazapine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.28e-05	0.000344	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000343	CcSEcCtD
Mirtazapine—Cough—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000343	CcSEcCtD
Mirtazapine—Pain—Indinavir—acquired immunodeficiency syndrome	9.21e-05	0.000341	CcSEcCtD
Mirtazapine—Constipation—Indinavir—acquired immunodeficiency syndrome	9.21e-05	0.000341	CcSEcCtD
Mirtazapine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.2e-05	0.000341	CcSEcCtD
Mirtazapine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.2e-05	0.000341	CcSEcCtD
Mirtazapine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.2e-05	0.000341	CcSEcCtD
Mirtazapine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.00034	CcSEcCtD
Mirtazapine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.17e-05	0.00034	CcSEcCtD
Mirtazapine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.16e-05	0.000339	CcSEcCtD
Mirtazapine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.16e-05	0.000339	CcSEcCtD
Mirtazapine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.15e-05	0.000339	CcSEcCtD
Mirtazapine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.14e-05	0.000339	CcSEcCtD
Mirtazapine—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.14e-05	0.000338	CcSEcCtD
Mirtazapine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.12e-05	0.000338	CcSEcCtD
Mirtazapine—Nausea—Didanosine—acquired immunodeficiency syndrome	9.12e-05	0.000338	CcSEcCtD
Mirtazapine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000337	CcSEcCtD
Mirtazapine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.1e-05	0.000337	CcSEcCtD
Mirtazapine—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.000337	CcSEcCtD
Mirtazapine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000336	CcSEcCtD
Mirtazapine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.07e-05	0.000336	CcSEcCtD
Mirtazapine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000336	CcSEcCtD
Mirtazapine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.05e-05	0.000335	CcSEcCtD
Mirtazapine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000335	CcSEcCtD
Mirtazapine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000335	CcSEcCtD
Mirtazapine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000335	CcSEcCtD
Mirtazapine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.01e-05	0.000334	CcSEcCtD
Mirtazapine—Oedema—Ritonavir—acquired immunodeficiency syndrome	9e-05	0.000334	CcSEcCtD
Mirtazapine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	8.98e-05	0.000333	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000333	CcSEcCtD
Mirtazapine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.000332	CcSEcCtD
Mirtazapine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	8.93e-05	0.000331	CcSEcCtD
Mirtazapine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.00033	CcSEcCtD
Mirtazapine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	8.88e-05	0.000329	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000329	CcSEcCtD
Mirtazapine—Shock—Ritonavir—acquired immunodeficiency syndrome	8.86e-05	0.000328	CcSEcCtD
Mirtazapine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	8.85e-05	0.000328	CcSEcCtD
Mirtazapine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000328	CcSEcCtD
Mirtazapine—Cough—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000327	CcSEcCtD
Mirtazapine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	8.84e-05	0.000327	CcSEcCtD
Mirtazapine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.000327	CcSEcCtD
Mirtazapine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	8.82e-05	0.000327	CcSEcCtD
Mirtazapine—Dizziness—Stavudine—acquired immunodeficiency syndrome	8.81e-05	0.000326	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	8.81e-05	0.000326	CcSEcCtD
Mirtazapine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	8.81e-05	0.000326	CcSEcCtD
Mirtazapine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000326	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	8.79e-05	0.000325	CcSEcCtD
Mirtazapine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.000325	CcSEcCtD
Mirtazapine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	8.78e-05	0.000325	CcSEcCtD
Mirtazapine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	8.77e-05	0.000325	CcSEcCtD
Mirtazapine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000324	CcSEcCtD
Mirtazapine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	8.74e-05	0.000324	CcSEcCtD
Mirtazapine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000324	CcSEcCtD
Mirtazapine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	8.71e-05	0.000322	CcSEcCtD
Mirtazapine—Constipation—Efavirenz—acquired immunodeficiency syndrome	8.7e-05	0.000322	CcSEcCtD
Mirtazapine—Pain—Efavirenz—acquired immunodeficiency syndrome	8.7e-05	0.000322	CcSEcCtD
Mirtazapine—Rash—Nevirapine—acquired immunodeficiency syndrome	8.7e-05	0.000322	CcSEcCtD
Mirtazapine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	8.69e-05	0.000322	CcSEcCtD
Mirtazapine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	8.68e-05	0.000322	CcSEcCtD
Mirtazapine—Dizziness—Abacavir—acquired immunodeficiency syndrome	8.68e-05	0.000322	CcSEcCtD
Mirtazapine—Oedema—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000321	CcSEcCtD
Mirtazapine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	8.66e-05	0.000321	CcSEcCtD
Mirtazapine—Headache—Nevirapine—acquired immunodeficiency syndrome	8.65e-05	0.00032	CcSEcCtD
Mirtazapine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000319	CcSEcCtD
Mirtazapine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000319	CcSEcCtD
Mirtazapine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000319	CcSEcCtD
Mirtazapine—Infection—Saquinavir—acquired immunodeficiency syndrome	8.61e-05	0.000319	CcSEcCtD
Mirtazapine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	8.6e-05	0.000318	CcSEcCtD
Mirtazapine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.000318	CcSEcCtD
Mirtazapine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.000317	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000317	CcSEcCtD
Mirtazapine—Urticaria—Indinavir—acquired immunodeficiency syndrome	8.56e-05	0.000317	CcSEcCtD
Mirtazapine—Shock—Saquinavir—acquired immunodeficiency syndrome	8.53e-05	0.000316	CcSEcCtD
Mirtazapine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000316	CcSEcCtD
Mirtazapine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.000315	CcSEcCtD
Mirtazapine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.000315	CcSEcCtD
Mirtazapine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000315	CcSEcCtD
Mirtazapine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.5e-05	0.000315	CcSEcCtD
Mirtazapine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.49e-05	0.000314	CcSEcCtD
Mirtazapine—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.47e-05	0.000314	CcSEcCtD
Mirtazapine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.000314	CcSEcCtD
Mirtazapine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000312	CcSEcCtD
Mirtazapine—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.43e-05	0.000312	CcSEcCtD
Mirtazapine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.42e-05	0.000312	CcSEcCtD
Mirtazapine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000312	CcSEcCtD
Mirtazapine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.41e-05	0.000312	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.41e-05	0.000311	CcSEcCtD
Mirtazapine—Rash—Stavudine—acquired immunodeficiency syndrome	8.4e-05	0.000311	CcSEcCtD
Mirtazapine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.4e-05	0.000311	CcSEcCtD
Mirtazapine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.39e-05	0.000311	CcSEcCtD
Mirtazapine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.39e-05	0.000311	CcSEcCtD
Mirtazapine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.38e-05	0.00031	CcSEcCtD
Mirtazapine—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.37e-05	0.00031	CcSEcCtD
Mirtazapine—Headache—Stavudine—acquired immunodeficiency syndrome	8.35e-05	0.000309	CcSEcCtD
Mirtazapine—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.35e-05	0.000309	CcSEcCtD
Mirtazapine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000309	CcSEcCtD
Mirtazapine—Pain—Delavirdine—acquired immunodeficiency syndrome	8.33e-05	0.000308	CcSEcCtD
Mirtazapine—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.33e-05	0.000308	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.32e-05	0.000308	CcSEcCtD
Mirtazapine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.31e-05	0.000308	CcSEcCtD
Mirtazapine—Rash—Abacavir—acquired immunodeficiency syndrome	8.28e-05	0.000307	CcSEcCtD
Mirtazapine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.27e-05	0.000306	CcSEcCtD
Mirtazapine—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.000306	CcSEcCtD
Mirtazapine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000306	CcSEcCtD
Mirtazapine—Headache—Abacavir—acquired immunodeficiency syndrome	8.22e-05	0.000305	CcSEcCtD
Mirtazapine—Infection—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000304	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000304	CcSEcCtD
Mirtazapine—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.2e-05	0.000304	CcSEcCtD
Mirtazapine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.19e-05	0.000304	CcSEcCtD
Mirtazapine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.14e-05	0.000302	CcSEcCtD
Mirtazapine—Shock—Lamivudine—acquired immunodeficiency syndrome	8.13e-05	0.000301	CcSEcCtD
Mirtazapine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.0003	CcSEcCtD
Mirtazapine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.1e-05	0.0003	CcSEcCtD
Mirtazapine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.1e-05	0.0003	CcSEcCtD
Mirtazapine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.09e-05	0.0003	CcSEcCtD
Mirtazapine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.09e-05	0.000299	CcSEcCtD
Mirtazapine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.000298	CcSEcCtD
Mirtazapine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.000298	CcSEcCtD
Mirtazapine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000297	CcSEcCtD
Mirtazapine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.03e-05	0.000297	CcSEcCtD
Mirtazapine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.02e-05	0.000297	CcSEcCtD
Mirtazapine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000297	CcSEcCtD
Mirtazapine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000296	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	7.96e-05	0.000295	CcSEcCtD
Mirtazapine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.94e-05	0.000294	CcSEcCtD
Mirtazapine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	7.94e-05	0.000294	CcSEcCtD
Mirtazapine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000294	CcSEcCtD
Mirtazapine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	7.92e-05	0.000294	CcSEcCtD
Mirtazapine—Nausea—Stavudine—acquired immunodeficiency syndrome	7.92e-05	0.000293	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.000292	CcSEcCtD
Mirtazapine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.000292	CcSEcCtD
Mirtazapine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	7.84e-05	0.00029	CcSEcCtD
Mirtazapine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.83e-05	0.00029	CcSEcCtD
Mirtazapine—Nausea—Abacavir—acquired immunodeficiency syndrome	7.8e-05	0.000289	CcSEcCtD
Mirtazapine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	7.78e-05	0.000288	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.77e-05	0.000288	CcSEcCtD
Mirtazapine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	7.76e-05	0.000288	CcSEcCtD
Mirtazapine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	7.74e-05	0.000287	CcSEcCtD
Mirtazapine—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.73e-05	0.000286	CcSEcCtD
Mirtazapine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.000286	CcSEcCtD
Mirtazapine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.000286	CcSEcCtD
Mirtazapine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000285	CcSEcCtD
Mirtazapine—Constipation—Ritonavir—acquired immunodeficiency syndrome	7.7e-05	0.000285	CcSEcCtD
Mirtazapine—Pain—Ritonavir—acquired immunodeficiency syndrome	7.7e-05	0.000285	CcSEcCtD
Mirtazapine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.000285	CcSEcCtD
Mirtazapine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.000285	CcSEcCtD
Mirtazapine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	7.66e-05	0.000284	CcSEcCtD
Mirtazapine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000283	CcSEcCtD
Mirtazapine—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.62e-05	0.000282	CcSEcCtD
Mirtazapine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000279	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000279	CcSEcCtD
Mirtazapine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.5e-05	0.000278	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.48e-05	0.000277	CcSEcCtD
Mirtazapine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.48e-05	0.000277	CcSEcCtD
Mirtazapine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.47e-05	0.000277	CcSEcCtD
Mirtazapine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.42e-05	0.000275	CcSEcCtD
Mirtazapine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000275	CcSEcCtD
Mirtazapine—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.41e-05	0.000275	CcSEcCtD
Mirtazapine—Pain—Saquinavir—acquired immunodeficiency syndrome	7.41e-05	0.000275	CcSEcCtD
Mirtazapine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.37e-05	0.000273	CcSEcCtD
Mirtazapine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.37e-05	0.000273	CcSEcCtD
Mirtazapine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.36e-05	0.000273	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.36e-05	0.000273	CcSEcCtD
Mirtazapine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000272	CcSEcCtD
Mirtazapine—Rash—Zidovudine—acquired immunodeficiency syndrome	7.3e-05	0.000271	CcSEcCtD
Mirtazapine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.3e-05	0.00027	CcSEcCtD
Mirtazapine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.3e-05	0.00027	CcSEcCtD
Mirtazapine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.00027	CcSEcCtD
Mirtazapine—Headache—Zidovudine—acquired immunodeficiency syndrome	7.26e-05	0.000269	CcSEcCtD
Mirtazapine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.2e-05	0.000267	CcSEcCtD
Mirtazapine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.19e-05	0.000266	CcSEcCtD
Mirtazapine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000266	CcSEcCtD
Mirtazapine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.15e-05	0.000265	CcSEcCtD
Mirtazapine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000265	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.14e-05	0.000264	CcSEcCtD
Mirtazapine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.13e-05	0.000264	CcSEcCtD
Mirtazapine—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.12e-05	0.000264	CcSEcCtD
Mirtazapine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000264	CcSEcCtD
Mirtazapine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000264	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000263	CcSEcCtD
Mirtazapine—Pain—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000262	CcSEcCtD
Mirtazapine—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000262	CcSEcCtD
Mirtazapine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.99e-05	0.000259	CcSEcCtD
Mirtazapine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.96e-05	0.000258	CcSEcCtD
Mirtazapine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.89e-05	0.000255	CcSEcCtD
Mirtazapine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.89e-05	0.000255	CcSEcCtD
Mirtazapine—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.88e-05	0.000255	CcSEcCtD
Mirtazapine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000254	CcSEcCtD
Mirtazapine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000254	CcSEcCtD
Mirtazapine—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.85e-05	0.000254	CcSEcCtD
Mirtazapine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000252	CcSEcCtD
Mirtazapine—Rash—Indinavir—acquired immunodeficiency syndrome	6.79e-05	0.000252	CcSEcCtD
Mirtazapine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.79e-05	0.000251	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.00025	CcSEcCtD
Mirtazapine—Headache—Indinavir—acquired immunodeficiency syndrome	6.75e-05	0.00025	CcSEcCtD
Mirtazapine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.73e-05	0.000249	CcSEcCtD
Mirtazapine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.66e-05	0.000247	CcSEcCtD
Mirtazapine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000246	CcSEcCtD
Mirtazapine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000243	CcSEcCtD
Mirtazapine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000242	CcSEcCtD
Mirtazapine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000242	CcSEcCtD
Mirtazapine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.47e-05	0.00024	CcSEcCtD
Mirtazapine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.46e-05	0.000239	CcSEcCtD
Mirtazapine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.44e-05	0.000239	CcSEcCtD
Mirtazapine—Rash—Efavirenz—acquired immunodeficiency syndrome	6.42e-05	0.000238	CcSEcCtD
Mirtazapine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.41e-05	0.000237	CcSEcCtD
Mirtazapine—Nausea—Indinavir—acquired immunodeficiency syndrome	6.4e-05	0.000237	CcSEcCtD
Mirtazapine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.39e-05	0.000237	CcSEcCtD
Mirtazapine—Headache—Efavirenz—acquired immunodeficiency syndrome	6.38e-05	0.000236	CcSEcCtD
Mirtazapine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.000236	CcSEcCtD
Mirtazapine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.22e-05	0.00023	CcSEcCtD
Mirtazapine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.19e-05	0.000229	CcSEcCtD
Mirtazapine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.16e-05	0.000228	CcSEcCtD
Mirtazapine—Rash—Delavirdine—acquired immunodeficiency syndrome	6.14e-05	0.000227	CcSEcCtD
Mirtazapine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000227	CcSEcCtD
Mirtazapine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000227	CcSEcCtD
Mirtazapine—Headache—Delavirdine—acquired immunodeficiency syndrome	6.1e-05	0.000226	CcSEcCtD
Mirtazapine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000226	CcSEcCtD
Mirtazapine—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000224	CcSEcCtD
Mirtazapine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.95e-05	0.000221	CcSEcCtD
Mirtazapine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.93e-05	0.00022	CcSEcCtD
Mirtazapine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.93e-05	0.00022	CcSEcCtD
Mirtazapine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.85e-05	0.000217	CcSEcCtD
Mirtazapine—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.78e-05	0.000214	CcSEcCtD
Mirtazapine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.73e-05	0.000212	CcSEcCtD
Mirtazapine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.73e-05	0.000212	CcSEcCtD
Mirtazapine—Rash—Ritonavir—acquired immunodeficiency syndrome	5.68e-05	0.00021	CcSEcCtD
Mirtazapine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.00021	CcSEcCtD
Mirtazapine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.00021	CcSEcCtD
Mirtazapine—Headache—Ritonavir—acquired immunodeficiency syndrome	5.64e-05	0.000209	CcSEcCtD
Mirtazapine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.51e-05	0.000204	CcSEcCtD
Mirtazapine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.47e-05	0.000203	CcSEcCtD
Mirtazapine—Rash—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000202	CcSEcCtD
Mirtazapine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000202	CcSEcCtD
Mirtazapine—Headache—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000201	CcSEcCtD
Mirtazapine—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.35e-05	0.000198	CcSEcCtD
Mirtazapine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.26e-05	0.000195	CcSEcCtD
Mirtazapine—Rash—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000193	CcSEcCtD
Mirtazapine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000193	CcSEcCtD
Mirtazapine—Headache—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000192	CcSEcCtD
Mirtazapine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.15e-05	0.000191	CcSEcCtD
Mirtazapine—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.91e-05	0.000182	CcSEcCtD
Mirtazapine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000347	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.03e-05	0.000347	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.03e-05	0.000347	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.03e-05	0.000347	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.02e-05	0.000346	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000343	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2e-05	0.000342	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2e-05	0.000342	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2e-05	0.000342	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.99e-05	0.000341	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.98e-05	0.000338	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.97e-05	0.000337	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.95e-05	0.000333	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.000332	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.000332	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.000331	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.000329	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.000328	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.91e-05	0.000326	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000326	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.000324	CbGpPWpGaD
Mirtazapine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000324	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.00032	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.00032	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.86e-05	0.000317	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.86e-05	0.000317	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.85e-05	0.000317	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.85e-05	0.000317	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.85e-05	0.000316	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000315	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000315	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.84e-05	0.000315	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.84e-05	0.000314	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.83e-05	0.000313	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.82e-05	0.000312	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.81e-05	0.00031	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.81e-05	0.000309	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.81e-05	0.000309	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000308	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000305	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.000303	CbGpPWpGaD
Mirtazapine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.77e-05	0.000302	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.77e-05	0.000302	CbGpPWpGaD
Mirtazapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.76e-05	0.000301	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.76e-05	0.0003	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.000298	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000296	CbGpPWpGaD
Mirtazapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.73e-05	0.000296	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.72e-05	0.000295	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.72e-05	0.000295	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.71e-05	0.000292	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.7e-05	0.000291	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.7e-05	0.00029	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	1.7e-05	0.00029	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.000288	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000288	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.68e-05	0.000288	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000285	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.66e-05	0.000283	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.000283	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000282	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000281	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.000281	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.64e-05	0.00028	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.63e-05	0.000279	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000278	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.61e-05	0.000276	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.6e-05	0.000273	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.59e-05	0.000272	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.57e-05	0.000268	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.57e-05	0.000268	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.57e-05	0.000268	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.55e-05	0.000265	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.55e-05	0.000265	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.55e-05	0.000264	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000264	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.000264	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.54e-05	0.000264	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.54e-05	0.000263	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.54e-05	0.000263	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.53e-05	0.000262	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.53e-05	0.000261	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.52e-05	0.00026	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.00026	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.52e-05	0.00026	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.00026	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000258	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000257	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.000257	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.5e-05	0.000257	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.5e-05	0.000257	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000256	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.5e-05	0.000256	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.49e-05	0.000255	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.49e-05	0.000255	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.49e-05	0.000255	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000252	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000252	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000249	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.45e-05	0.000249	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.45e-05	0.000249	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000245	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.43e-05	0.000245	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000241	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.4e-05	0.00024	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000238	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.39e-05	0.000237	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000237	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000236	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.38e-05	0.000236	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000236	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.38e-05	0.000235	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000234	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000234	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000232	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.35e-05	0.000231	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000227	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.32e-05	0.000225	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.32e-05	0.000225	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.000224	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000222	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.3e-05	0.000222	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.3e-05	0.000222	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000221	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000221	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.000221	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000218	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.27e-05	0.000217	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.27e-05	0.000217	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.000217	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.26e-05	0.000215	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000212	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.23e-05	0.00021	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.19e-05	0.000204	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000202	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.18e-05	0.000202	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.18e-05	0.000202	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000201	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.17e-05	0.0002	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.15e-05	0.000197	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.14e-05	0.000195	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.14e-05	0.000194	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000194	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000192	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000191	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.11e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.000189	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000189	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000186	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000184	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000183	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.05e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.05e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000176	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000176	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000172	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1e-05	0.000172	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1e-05	0.000171	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1e-05	0.000171	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.96e-06	0.00017	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.88e-06	0.000169	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.87e-06	0.000169	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.85e-06	0.000168	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.74e-06	0.000167	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.74e-06	0.000166	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.72e-06	0.000166	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.7e-06	0.000166	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.67e-06	0.000165	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.58e-06	0.000164	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.56e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.52e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.38e-06	0.00016	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.12e-06	0.000156	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.04e-06	0.000155	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.98e-06	0.000154	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.89e-06	0.000152	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.87e-06	0.000152	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.85e-06	0.000151	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.84e-06	0.000151	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.71e-06	0.000149	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.71e-06	0.000149	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.7e-06	0.000149	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.68e-06	0.000148	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.55e-06	0.000146	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.52e-06	0.000146	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	8.49e-06	0.000145	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.15e-06	0.000139	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.11e-06	0.000139	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.09e-06	0.000138	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.03e-06	0.000137	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.99e-06	0.000137	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.91e-06	0.000135	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.68e-06	0.000131	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.65e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.33e-06	0.000125	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.3e-06	0.000125	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.89e-06	0.000118	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.82e-06	0.000117	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.79e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.22e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.19e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.08e-06	0.000104	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.05e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.95e-06	0.000102	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.92e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.92e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.89e-06	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.76e-06	9.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.73e-06	9.79e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.47e-06	9.36e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.22e-06	8.93e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.2e-06	8.88e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.14e-06	8.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.13e-06	8.77e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.11e-06	8.74e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.1e-06	8.72e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.03e-06	8.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.01e-06	8.56e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.79e-06	8.19e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.72e-06	8.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.67e-06	7.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.65e-06	7.95e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.52e-06	7.72e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.49e-06	7.68e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.45e-06	7.62e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.31e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.01e-06	6.86e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.81e-06	6.51e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.66e-06	6.25e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.58e-06	6.11e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.5e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.48e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.38e-06	5.78e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.07e-06	5.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.02e-06	5.16e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.01e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.96e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.94e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.75e-06	4.7e-05	CbGpPWpGaD
